Zai Lab (ZLAB) Amortization of Deferred Charges (2024 - 2025)
Zai Lab (ZLAB) posted Amortization of Deferred Charges of -$1.4 million for Q1 2026, down 3.26% sequentially from -$1.3 million in Q4 2025, and down 4.66% YoY from -$1.5 million in Q1 2025.
Analysis
Zai Lab (ZLAB) Amortization of Deferred Charges (2024 - 2025) Analysis & Trends
Zai Lab has reported Amortization of Deferred Charges for 9 years, with the latest figure at -$1.4 million in Q1 2026.
- Quarterly Amortization of Deferred Charges fell 4.66% year-over-year to -$1.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$5.4 million (down 34.68% YoY) and the FY2025 annual result came in at -$5.3 million, down 51.7% from the prior year.
- Amortization of Deferred Charges retreated to -$1.4 million in Q1 2026 per ZLAB's latest filing, from -$1.3 million in the prior quarter.
- Over five years, Amortization of Deferred Charges peaked at -$561000.0 in Q4 2022 and troughed at -$1.4 million in Q1 2026.
- A 5-year average of -$955176.5 and a median of -$839000.0 in 2024 frame the typical range for Amortization of Deferred Charges.
- The sharpest annual moves came in 2022 and 2024: Amortization of Deferred Charges slumped 807.69% in 2022, then climbed 26.01% in 2024.
- Over 5 years, Amortization of Deferred Charges stood at -$561000.0 in 2022, then slumped by 49.02% to -$836000.0 in 2023, then fell by 19.86% to -$1.0 million in 2024, then sank by 34.63% to -$1.3 million in 2025, then retreated by 3.26% to -$1.4 million in 2026.
- According to Business Quant data, Amortization of Deferred Charges over the past three periods registered -$1.4 million, -$1.3 million, and -$1.3 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn |
| 10 | Zai Lab | 2.94 Bn | 2.23 Bn | 58.15 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2025 | 90,000.00 |
| Jun 30, 2025 | 104,000.00 |
| Mar 31, 2024 | 700,000.00 |